Term
|
Definition
best for increasing HDL (1) lowers TG synthesis (2) decreased lipolysis in adipose tissue (decreased FFA) (3) reduced hepatic clearance of HDL |
|
|
Term
|
Definition
Fibrate (1st); marked reduction in VLDL (1) LPL synthesis (clearance of TG-rich lipoproteins) (2) inhibition of apoC III expression (enhance VLDL clearance) -GALLSTONES |
|
|
Term
|
Definition
Fibrate; marked reduction in VLDL |
|
|
Term
|
Definition
Fibrate; marked reduction in VLDL |
|
|
Term
|
Definition
Fibrate; marked reduction in VLDL |
|
|
Term
|
Definition
Fibrate; marked reduction in VLDL |
|
|
Term
|
Definition
Bile Acid Sequestrants (binds negatively charged bile acids) -reduces LDL; slight increase in TG and HDL -COMBO w/ statins |
|
|
Term
|
Definition
Bile Acid Sequestrants (binds negatively charged bile acids) -reduces LDL; slight increase in TG and HDL -COMBO w/ statins |
|
|
Term
|
Definition
Bile Acid Sequestrants (binds negatively charged bile acids) -reduces LDL; slight increase in TG and HDL -COMBO w/ statins |
|
|
Term
|
Definition
HMG-CoA reductase inhibitor (statins) -1st one studied |
|
|
Term
|
Definition
HMG-CoA reductase inhibitor (statins) -1st approved by FDA |
|
|
Term
|
Definition
HMG-CoA reductase inhibitor (statins) |
|
|
Term
|
Definition
HMG-CoA reductase inhibitor (statins) |
|
|
Term
|
Definition
HMG-CoA reductase inhibitor (statins) |
|
|
Term
|
Definition
HMG-CoA reductase inhibitor (statins) -longer t1/2 (lipitor) |
|
|
Term
|
Definition
HMG-CoA reductase inhibitor (statins) -longer t1/2 (crestor) |
|
|
Term
|
Definition
inhibits enterocyte abs. of cholesterol in intestine -new drug (best in combo w/ statins) |
|
|
Term
|
Definition
weak diuretics, lower BP, improve symptoms of congestion |
|
|
Term
|
Definition
|
|
Term
amiloride, spironolactone |
|
Definition
potassium sparing diuretics (reduce K+ depletion) |
|
|
Term
|
Definition
Central sympathetic drug, alpha 2 agonist (pregnancy) |
|
|
Term
|
Definition
central sympathetic, alpha 2 agonist, used when traditional means to control BP fails |
|
|
Term
|
Definition
adrenergic neuron blocking agent |
|
|
Term
|
Definition
adrenergic neuron blocking agent |
|
|
Term
|
Definition
adrenergic beta receptor blocker (non-selective) |
|
|
Term
|
Definition
adrenergic beta receptor blocker (B1 selective) |
|
|
Term
|
Definition
adrenergic beta receptor blocker (B1 selective) |
|
|
Term
|
Definition
adrenergic beta receptor blocker (non-selective) -also alpha-1 blocker |
|
|
Term
|
Definition
adrenergic beat receptor blocker (B1 selective) |
|
|
Term
Adrenergic alpha receptor blockers |
|
Definition
blocks alpha 1; given at bed to avoid orthostatic effect |
|
|
Term
|
Definition
direct vasodilator (use w/ beta-blocker) -short t1/2; lupus-like syndrome -NO release |
|
|
Term
|
Definition
direct vasodilator (use w/ beta-blocker) -NO release -avoid prolonged use in renal failure (CN build-up) |
|
|
Term
|
Definition
direct vasodilator (use w/ beta-blocker) -hyperpolarize SM (opening K channels) |
|
|
Term
Amilodipine (felodipine. isradipine) |
|
Definition
Calcium channel blocker (vasoselective = dihydropyridines) |
|
|
Term
|
Definition
Calcium channel blocker (vasoselective = dihydropyridines) |
|
|
Term
|
Definition
Calcium channel blocker (nondihydropyridines) |
|
|
Term
|
Definition
Calcium channel blockers (nondihydropyridines) |
|
|
Term
(end w/ pril) captopril, enalapril, lisinopril, ramipril, quinapril, fosinopril |
|
Definition
|
|
Term
(end in -sartan) losartan, irbesartan, valsartan, candesartan, olmesartan, telmisartan |
|
Definition
Angiotensin receptor blocker |
|
|